Products - Motor neurone disease | Topic | NICE

Showing 3 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

Tofersen for treating amyotrophic lateral sclerosis caused by SOD1 gene mutations [ID3767]
Status:
In development
Programme:
Highly specialised technologies guidance
Expected publication date:
17 March 2027
Masitinib with riluzole for treating amyotrophic lateral sclerosis [ID6257]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Pegcetacoplan for amyotrophic lateral sclerosis [TSID10594]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC